GlassScriptPhysician profile
Justin B Field
NPI 1578946117
$49,138.77
in general payments reported to CMS, 2019-2025
41 companies · $4,676 in 2025
The $4,676 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,702 · 2020: $384 · 2021: $11K · 2022: $20K · 2023: $6,511 · 2024: $4,214 · 2025: $4,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,794 · Travel and Lodging: $5,107 · Grant: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,794.01 |
| Travel and Lodging | $5,107.49 |
| Grant | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26,202.28 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Affera Mapping System |
| Abbott Laboratories | $11,827.85 | 2019-2025 | Aveir, Ensite Precision, Advisor |
| Biotronik INC. | $3,873.51 | 2019-2025 | Biomonitor |
| Biosense Webster, INC. | $1,062.30 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Novartis Pharmaceuticals Corporation | $646.89 | 2019-2025 | |
| Boston Scientific Corporation | $628.59 | 2019-2025 | General - Therapies, Watchman Access System |
| Pfizer INC. | $527.52 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $509.45 | 2023-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $380.76 | 2024-2025 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $378.69 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $354.90 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $279.21 | 2023-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $194.85 | 2023-2025 | |
| Novo Nordisk INC | $194.71 | 2024-2025 | Wegovy, Ozempic |
| Janssen Pharmaceuticals, INC | $185.05 | 2019-2024 | Xarelto |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $166.20 | 2019-2025 | Farxiga, Wainua |
| Esperion Therapeutics, INC. | $165.08 | 2024-2025 | Nexletol |
| Abiomed | $164.57 | 2019-2025 | |
| Shockwave Medical, INC | $158.96 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $141.29 | 2023-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $130.58 | 2020-2025 | |
| Heartflow, INC. | $119.08 | 2023-2024 | Ffrct |
| Takeda Pharmaceuticals U.S.A., INC. | $118.64 | 2025 | Entyvio |
| Azurity Pharmaceuticals, INC. | $89.35 | 2024-2025 | Horizant, Edarbi, Edarbyclor |
| Philips North America LLC | $83.73 | 2024-2025 | (Ck7) Extended Holter, Ecc Solutions, Extended Holter |
| Impulse Dynamics (USA) INC. | $75.13 | 2024 | Optimizer |
| Cvrx, INC. | $68.55 | 2024-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $52.45 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $51.86 | 2024 | Arcalyst |
| Baxter Healthcare | $49.90 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Bridgebio Pharma, INC. | $42.97 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $29.46 | 2025 | Assure Wcd |
| Irhythm Technologies, INC. | $23.39 | 2024 | Zio Xt Patch, Zio Monitor |
| Regeneron Healthcare Solutions, INC. | $23.31 | 2025 | Evkeeza |
| Cleerly, INC. | $23.02 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Lantheus Medical Imaging, INC. | $22.68 | 2023 | Definity |
| Lilly USA, LLC | $22.63 | 2025 | Zepbound |
| Altathera Pharmaceuticals LLC | $22.49 | 2025 | Sotalol Hydrochloride |
| Cordis US Corp. | $21.06 | 2025 | Mynx Control Venous |
| Edwards Lifesciences Corporation | $14.21 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| W. L. Gore & Associates, INC. | $11.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.